Daily Ards Research Analysis

BACKGROUND: Sepsis-Induced Acute Respiratory Distress Syndrome (SI-ARDS) presents significant diagnostic and prognostic challenges due to its complex clinical manifestations and high mortality rate. METHODS: We developed a deep Knowledge-Driven multi-Modal Fusion (KDMF) framework for the accurate diagnosis and prognosis of SI-ARDS. The model leverages multi-modal data, including CT images, CT reports, and laboratory indicators, alongside a disease-specific knowledge graph. RESULTS: KDMF achieves superior performance in predicting SI-ARDS incidence (AUC 0.930) and time to 28-day mortality (AUC 0.843, C-index 0.833). Comprehensive error analysis and ablation studies demonstrate the critical contributions of each data modality and the integrated knowledge graph. CONCLUSIONS: The results highlight the potential of KDMF to enhance early intervention and treatment strategies, underscoring the robustness and interpretability of the framework in clinical applications. Sepsis is a life-threatening condition that can lead to a serious lung injury called ARDS, which is difficult to diagnose early and has a high risk of death. This study developed a computer model called KDMF to help medical practitioners identify sepsis patients who are likely to develop ARDS and predict their risk of death within 28 days. The model combines multiple types of patient data—including scans of the lungs, text from radiology reports, and routine lab results—along with medical knowledge built into the system. When tested on real patient data, the model was highly accurate at predicting both the onset of ARDS and patient survival. It also helped explain which factors, such as specific symptoms or lab values, were most important for its predictions. This tool could support doctors in making faster and more informed decisions, potentially improving treatment and outcomes for high-risk patients in the intensive care unit.

OBJECTIVES: To undertake a systematic review evaluating the clinical and cost-effectiveness of technology-enhanced positive end-expiratory pressure (PEEP) optimization strategies in adults and children receiving invasive mechanical ventilation on an ICU. DATA SOURCES: We searched key electronic databases (including MEDLINE and Embase) from inception to July 2024. STUDY SELECTION: We included randomized studies examining clinical or cost-effectiveness of technology-enhanced PEEP optimization strategies compared with standard care or an alternative PEEP optimization strategy in adults and children. The primary outcome was duration of mechanical ventilation and secondary outcomes were clinical effectiveness (e.g., mortality) and efficacy (e.g., PEEP). DATA EXTRACTION: Two reviewers independently assessed eligibility, extracted data, assessed risk of bias (Revised Cochrane tool) and performed Grading of Recommendations Assessment, Development and Evaluation evidence certainty assessments. DATA SYNTHESIS: Our database and trial register search retrieved 8845 results, of which 34 studies (2951 patients) were included. Eight studies were at low risk of bias. Across studies, 7 technologies were evaluated, most commonly esophageal balloon measurement of transpulmonary pressure (10 studies), electrical impedance tomography (7 studies), pressure-volume curve analysis (6 studies), and fully automated closed-loop ventilation (5 studies). Meta-analysis used random-effects models. Duration of mechanical ventilation was reported in only three studies (172 patients, two technologies) and there was no effect compared with standard care (mean difference -0.06 d; 95% CI, -0.20 to 0.09; very low-certainty evidence).For 28-day mortality (10 studies; 1,719 patients; six technologies), technology-enhanced PEEP optimization reduced 28-day mortality (risk ratio 0.69; 95% CI, 0.52-0.93; very low-certainty evidence). No significant differences were found for other clinical-effectiveness outcomes. We identified no evidence in children or on cost-effectiveness. CONCLUSIONS: Technology-enhanced PEEP optimization strategies did not reduce duration of mechanical ventilation, but these technologies may reduce mortality. Evidence certainty was low or very low, highlighting the urgent need for adequately powered randomized trials. REGISTRATION: PROSPERO (CRD42024555390).

OBJECTIVE: Acute respiratory distress syndrome (ARDS) drives early mortality in severe acute pancreatitis (AP). Since conventional tools often fail to capture complex physiological interactions, we aimed to develop and validate an interpretable machine learning (ML) model for early ARDS prediction and deploy it as a web-based calculator. METHODS: This multicenter retrospective study utilized data from the MIMIC-IV database for model development and internal validation, and an independent cohort from Changshu Hospital for external validation. Optimal predictors were identified through a hybrid feature selection strategy combining LASSO regression and the Boruta algorithm. Seven ML algorithms were constructed, including random forest (RF), extreme gradient boosting, support vector machine, logistic regression, light gradient boosting machine, k-nearest neighbors, and decision trees. Model performance was evaluated by discrimination (AUC), calibration curves, and clinical utility (DCA). Model interpretability was assessed using SHapley Additive exPlanations (SHAP) and partial dependence plots (PDP). RESULTS: A total of 905 patients from the MIMIC-IV cohort (25.0% ARDS incidence) and 126 from the external cohort (20.6% incidence) were included. Nine independent predictors were identified: body mass index (BMI), respiratory rate, temperature, SOFA score, white blood cell count, PO CONCLUSION: A high-performing, interpretable RF model was developed for early ARDS prediction in critically ill AP patients. The model effectively captured complex physiological interactions and demonstrated robustness across diverse populations. By integrating this algorithmic framework into a user-friendly web calculator, the tool supports personalized risk stratification and timely clinical decision-making.